The debate highlighted that TFEB effects vary by cell type and disease context, but specific safety windows for neurons versus glia remain undefined. This knowledge gap prevents rational dosing strategies for TFEB-targeted therapeutics. Source: Debate session sess_SDA-2026-04-03-gap-debate-20260403-222617-8eb5bdbc (Analysis: SDA-2026-04-03-gap-debate-20260403-222617-8eb5bdbc)
Landscape Summary: What are the tissue-specific safety thresholds for TFEB modulation in different brain regions? is a 0.75 priority gap in neuropharmacology. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What are the tissue-specific safety thresholds for TFEB modulation in different brain regions? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: